![Mark Kroll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Kroll
Direktor/Vorstandsmitglied bei
HAEMONETICS CORPORATION
Vermögen: 2 Mio $ am 30.06.2026
Profil
Mark W.
Kroll is an Independent Director at Haemonetics Corp.
since 2006.
Dr. Kroll is a Director at Medisyn Technologies, Inc. Dr. Kroll is a Director at San Francisco Opera Association.
Former roles include Director at Recombinetics, Inc., TriVirix International, Inc., NewCardio, Inc. from 2011 to 2012, Ionix Medical, Inc., and Secretary at Harbinger Medical, Inc. from 1993 to 2009.
Dr. Kroll was Independent Director at Axon Enterprise, Inc. from 2003 to 2024.
Dr. Kroll was Vice President-Research at MGC Diagnostics Corp.
in 1995.
Dr. Kroll was SVP & CTO-Cardiac Rhythm Management Division at St. Jude Medical LLC from 1995 to 2005.
Dr. Kroll was Vice President-Research & Development at Vital Health Technologies, Inc. in 1991.
Dr. Kroll was Vice President-Research & Development at Intercomp Co. in 1985.
Education includes an MBA from the University of St. Thomas (Texas) in 1990, undergraduate degree in 1975, graduate degree in 1983, and doctorate in 1987 from the College of Science & Engineering, and a doctorate from the University of Minnesota.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HAEMONETICS CORPORATION 0,06 % | 24.07.2026 | 27.295 ( 0,06 % ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Mark Kroll
| Unternehmen | Position | Beginn |
|---|---|---|
| HAEMONETICS CORPORATION | Direktor/Vorstandsmitglied | 01.01.2006 |
San Francisco Opera Association
 San Francisco Opera Association Movies/EntertainmentConsumer Services Owns and operates an opera theater | Direktor/Vorstandsmitglied | - |
Medisyn Technologies, Inc.
 Medisyn Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals, nutraceuticals, and animal health products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mark Kroll
| Unternehmen | Position | Ende |
|---|---|---|
| AXON ENTERPRISE, INC. | Direktor/Vorstandsmitglied | 09.05.2024 |
| NEWCARDIO, INC. | Vorsitzender | 24.06.2011 |
| ST JUDE MEDICAL INC | Corporate Officer/Principal | 01.07.2005 |
| MGC DIAGNOSTICS CORP | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 |
Vital Health Technologies, Inc.
 Vital Health Technologies, Inc. Financial ConglomeratesFinance Development stage company | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1991 |
Ausbildung von Mark Kroll
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
MGC Diagnostics Corp.
 MGC Diagnostics Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets non-invasive diagnostic systems | Health Technology |
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology Develops, manufactures and distributes cardiovascular medical devices | Health Technology |
Haemonetics Corp.
 Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Axon Enterprise, Inc.
 Axon Enterprise, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures advanced conducted electrical weapons and software | Electronic Technology |
Vital Health Technologies, Inc.
Vital Health Technologies, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Harbinger Medical, Inc.
 Harbinger Medical, Inc. Medical DistributorsDistribution Services Develops and markets diagnostic tools | Distribution Services |
Medisyn Technologies, Inc.
Medisyn Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals, nutraceuticals, and animal health products | Health Technology |
Recombinetics, Inc.
 Recombinetics, Inc. BiotechnologyHealth Technology Develops therapeutic applications for gene editing | Health Technology |
TriVirix International, Inc.
 TriVirix International, Inc. Medical SpecialtiesHealth Technology Manufactures electromechanical medical devices | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of St. Thomas (Texas)
 University of St. Thomas (Texas) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco Opera Association
San Francisco Opera Association Movies/EntertainmentConsumer Services Owns and operates an opera theater | Consumer Services |
NewCardio, Inc.
 NewCardio, Inc. Medical SpecialtiesHealth Technology Provides cardiac diagnostic technology and products | Health Technology |
Intercomp Co.
 Intercomp Co. Industrial MachineryProducer Manufacturing Manufactures Industrial Scales | Producer Manufacturing |
Ionix Medical, Inc.
 Ionix Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops medical devices for ablating benign growths and cancerous tumors | Health Technology |
College of Science & Engineering
 College of Science & Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
